Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans
- PMID: 38130992
- PMCID: PMC10733437
- DOI: 10.3389/fonc.2023.1250766
Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans
Abstract
Since the domestication of dogs 10,000 years ago, they have shared their living environment with humans and have co-evolved. The breeding process that dogs have undergone in only a few centuries has led to a significant accumulation of specific genetic alterations that could induce particular diseases in certain breeds. These canine diseases are similar to what is found in humans with several differences; therefore, comparing such diseases occurring in humans and dogs can help discover novel disease mechanisms, pathways, and causal genetic factors. Human angiosarcoma (AS) and canine hemangiosarcoma (HSA), which are sarcomas originating from endothelium, are examples of diseases shared between humans and dogs. They exhibit similar characteristics and clinical behaviors, although with some critical differences resulting from evolution. In this review, we will describe the similarities and differences in terms of clinical and molecular characteristics between human AS and canine HSA, and discuss how these similarities and differences can be applied to advance the treatment of these diseases.
Keywords: angiosarcoma; cancer heterogeneity; drug discovery; hemangiosarcoma; non-conventional animal model.
Copyright © 2023 Heishima, Aketa, Heishima and Kawachi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.Mol Cancer Res. 2019 Dec;17(12):2410-2421. doi: 10.1158/1541-7786.MCR-19-0221. Epub 2019 Sep 30. Mol Cancer Res. 2019. PMID: 31570656 Free PMC article.
-
Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma.Res Vet Sci. 2024 Feb;167:105120. doi: 10.1016/j.rvsc.2023.105120. Epub 2023 Dec 23. Res Vet Sci. 2024. PMID: 38150941 Review.
-
MicroRNA-214 and MicroRNA-126 Are Potential Biomarkers for Malignant Endothelial Proliferative Diseases.Int J Mol Sci. 2015 Oct 23;16(10):25377-91. doi: 10.3390/ijms161025377. Int J Mol Sci. 2015. PMID: 26512652 Free PMC article.
-
Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.PLoS One. 2020 Mar 25;15(3):e0229728. doi: 10.1371/journal.pone.0229728. eCollection 2020. PLoS One. 2020. PMID: 32210430 Free PMC article.
-
Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets.Vet Sci. 2023 Jun 5;10(6):387. doi: 10.3390/vetsci10060387. Vet Sci. 2023. PMID: 37368773 Free PMC article. Review.
Cited by
-
Analysis of VEGFR-2 and PDGFR-β expression in canine splenic hemangiosarcoma to identify drug repositioning candidates.Braz J Vet Med. 2024 Aug 6;46:e001524. doi: 10.29374/2527-2179.bjvm001524. eCollection 2024. Braz J Vet Med. 2024. PMID: 39131208 Free PMC article.
-
Genomic landscape and preclinical models of angiosarcoma.Mol Oncol. 2025 Apr;19(4):965-983. doi: 10.1002/1878-0261.13744. Epub 2024 Oct 5. Mol Oncol. 2025. PMID: 39367667 Free PMC article. Review.
References
-
- Davis SJ, Valla FR. Evidence for domestication of the dog 12,000 years ago in the Natufian of Israel. Nature (1978) 276(5688):608–10. doi: 10.1038/276608a0 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
